An observational study in Neurological Diseases, sponsored by Charite University, Berlin, Germany. Completed at 1 site in Germany. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-11-29.
Sponsored by Charite University, Berlin, Germany · Observational
This study examines the prognostic properties of immune parameters, clinical scores, electrophysiological tests (eeg, ssep, emg, eng) and functional imaging for the prediction of functional outcome one year after treatment on a neurological intensive care unit.
974 studies on the registry are indexed under Nervous System Diseases; 252 are open to participants now.
This study's enrollment of 46 is below the median of 127 across 318 observational studies indexed under Nervous System Diseases.
Browse Nervous System Diseases studies →Charite University, Berlin, Germany is the lead sponsor of 836 studies on the registry; 129 are open to participants now.
Counted across the registry records on this site, refreshed daily.
patients with severe neurological diseases treated on a neurological intensive care unit
Exclusion Criteria:
Patients with severe neurological diseases treated on the neurological intensive care unit
Predictive properties of immune parameters (IL6, IL10, mHLA-DR) for functional outcome one year after symptom onset
To evaluate of the predictive properties of immune parameters (IL6, IL10, mHLA-DR) for functional outcome one year after symptom onset
Time frame: one year after symptom onset
To evaluate of the predictive properties of clinical scores for functional outcome one year after symptom onset
To evaluate of the predictive properties of clinical scores for functional outcome one year after symptom onset
Time frame: one year after symptom onset
To evaluate of the predictive properties of electrophysiological measurements one year after symptom onset
To evaluate of the predictive properties of electrophysiological measurements one year after symptom onset
Time frame: one year after symptom onset
To evaluate of the predictive properties of conventional (DTI) and functional imaging (resting state) one year after symptom onset
To evaluate of the predictive properties of conventional (DTI) and functional imaging (resting state) one year after symptom onset
Time frame: one year after symptom onset
Transcriptome analyses
To perform transcriptome analyses to identify new biomarkers which may predict the one year- neurological outcome
Time frame: one year after symptom onset
Predictive properties of immune parameters in the cerebrovascular fluid for functional outcome one year after symptom onset
To evaluate of the predictive properties of immune parameters in the cerebrovascular fluid for functional outcome one year after symptom onset
Time frame: one year after symptom onset
Quality of life and occurence of depression in patients one year after symptom onset
To investigate the quality of life and the occurence of depression in patients one year after symptom onset
Time frame: one year after symptom onset
Quality of life and the occurence of depression and burnout syndrome in relatives
To investigate the quality of life and the occurence of depression and burnout syndrome in relatives of patients treated on the neurological intensive care unit one year after symptom onset
Time frame: one year after symptom onset
This study is completed, as verified in Nov 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Charite University, Berlin, Germany